Cardiogenic Shock

Semhar Z Tewelde; Stanley S Liu; Michael E Winters

doi:10.1016/j.ccl.2017.08.009

Cardiogenic Shock

Cardiol Clin. 2018 Feb;36(1):53-61. doi: 10.1016/j.ccl.2017.08.009.

Authors

Semhar Z Tewelde¹, Stanley S Liu², Michael E Winters³

Affiliations

¹ Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA.
² Division of Cardiovascular Medicine, University of Maryland School of Medicine, 110 South Paca Street 7-N-127, Baltimore, MD 21224, USA.
³ Emergency Medicine/Internal Medicine/Critical Care Program, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, Baltimore, MD 21201, USA. Electronic address: [email protected].

PMID: 29173681
DOI: 10.1016/j.ccl.2017.08.009

Abstract

Cardiogenic shock (CS) is a physiologic state in which cardiac pump function is inadequate to perfuse the tissues. If CS is not rapidly recognized and treated, tissue hypoperfusion can quickly lead to organ dysfunction and patient death. Evaluation of patients with suspected CS should include an electrocardiogram, chest radiograph, laboratory studies, and bedside echocardiogram. Initial resuscitation is directed toward restoring cardiac output and tissue perfusion. Mechanical circulatory support is indicated for patients with CS who do not respond to pharmacologic therapy. Ultimately, these patients should undergo emergent reperfusion therapy with either percutaneous coronary intervention or coronary artery bypass grafting.

Keywords: Cardiogenic shock; Dobutamine; Echocardiography; Hypoperfusion; Inotropic medications; Intra-aortic balloon pump counterpulsation; Percutaneous coronary intervention; Vasopressor medications.

Publication types

Review

MeSH terms

Advanced Cardiac Life Support / methods*
Echocardiography / methods*
Electrocardiography / methods*
Humans
Shock, Cardiogenic* / diagnosis
Shock, Cardiogenic* / epidemiology
Shock, Cardiogenic* / therapy